Citation Impact
Citing Papers
TCMSP: a database of systems pharmacology for drug discovery from herbal medicines
2014 Standout
Metagenomic analysis of gut microbiota modulatory effects of jujube (Ziziphus jujuba Mill.) polysaccharides in a colorectal cancer mouse model
2019 Standout
The association between consistent licorice ingestion, hypertension and hypokalaemia: a systematic review and meta-analysis
2017
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
2014 Standout
Systems approaches and polypharmacology for drug discovery from herbal medicines: An example using licorice
2013
The missing linkage: what pharmacogenetic associations are left to find inCYP3A?
2009
Review of Pharmacological Effects of Glycyrrhiza sp. and its Bioactive Compounds
2008 Standout
Biotransformation of Two β-Secretase Inhibitors Including Ring Opening and Contraction of a Pyrimidine Ring
2013
Cushing's syndrome
2015 Standout
Interpreting population pharmacokinetic‐pharmacodynamic analyses – a clinical viewpoint
2010
Targeting Amyloidogenic Processing of APP in Alzheimer’s Disease
2020
Scaling and systems biology for integrating multiple organs-on-a-chip
2013
Rethinking mechanisms, diagnosis and management of endometriosis
2019 Standout
Inhibitors of BACE for treating Alzheimer's disease: a fragment-based drug discovery story
2013
Model-based drug discovery: implementation and impact
2013
Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2012
Computational Methods in Drug Discovery
2014
Quantitative pharmacological analysis of antagonist binding kinetics at CRF1receptorsin vitroandin vivo
2011
Nano based drug delivery systems: recent developments and future prospects
2018 Standout
PharmGKB summary
2013
CURRENT PROGRESS IN STRUCTURE-BASED RATIONAL DRUG DESIGN MARKS A NEW MINDSET IN DRUG DISCOVERY
2013
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Microfluidic organs-on-chips
2014 Standout
Integration ofin silicoandin vitroplatforms for pharmacokinetic–pharmacodynamic modeling
2010
Alzheimer's disease
2016 Standout
TFOS DEWS II Management and Therapy Report
2017 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
The role of the blood–CNS barrier in CNS disorders and their treatment
2009
Efficacy of pulmonary insulin delivery in diabetic rats: Use of a model-based approach in the evaluation of insulin powder formulations
2008
Experimental models for predicting drug absorption and metabolism
2013
Microneedles for drug and vaccine delivery
2012 Standout
Engineering Challenges for Instrumenting and Controlling Integrated Organ-on-Chip Systems
2013
Medical treatment of endometriosis-related pain
2018
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Glycyrrhizin Binds to High-Mobility Group Box 1 Protein and Inhibits Its Cytokine Activities
2007 Standout
Intradermal Microneedle Delivery of Insulin Lispro Achieves Faster Insulin Absorption and Insulin Action than Subcutaneous Injection
2011
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Data-Mining for Sulfur and Fluorine: An Evaluation of Pharmaceuticals To Reveal Opportunities for Drug Design and Discovery
2013 Standout
Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations
2018
Update in Adrenocortical Carcinoma
2013
Combining an amyloid‐beta (Aβ) cleaving enzyme inhibitor with a γ‐secretase modulator results in an additive reduction of Aβ production
2014
The Organocatalytic Approach to Enantiopure 2H‐ and 3H‐Pyrroles: Inhibitors of the Hedgehog Signaling Pathway
2016 StandoutNobel
Licking latency with licorice
2005
Molecular Docking and Structure-Based Drug Design Strategies
2015 Standout
Chitin and chitosan polymers: Chemistry, solubility and fiber formation
2009 Standout
Molecular Docking: Shifting Paradigms in Drug Discovery
2019 Standout
Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation
2016 StandoutNobel
The Effects of Cadmium Toxicity
2020 Standout
Toxicological Effects of Glycyrrhiza glabra (Licorice): A Review
2017
Flavonoids Extracted from Licorice Prevents Colitis-Associated Carcinogenesis in AOM/DSS Mouse Model
2016
Current and emerging treatment options for endometriosis
2018
Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review
2018 Standout
N-Alkyl Carbazole Derivatives as New Tools for Alzheimer’s Disease: Preliminary Studies
2014
Organokatalytische Synthese von enantiomerenreinen 2H‐ und 3H‐Pyrrolen: Inhibitoren des Hedgehog‐Signalwegs
2016 StandoutNobel
Dogs and monkeys in preclinical drug development: the challenge of reducing and replacing
2013
Adrenocortical Carcinoma
2013
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
2016 Standout
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Works of Bart A. Ploeger being referenced
Explaining Variability in Tacrolimus Pharmacokinetics to Optimize Early Exposure in Adult Kidney Transplant Recipients
2009
Incorporating Receptor Theory in Mechanism-Based Pharmacokinetic-Pharmacodynamic (PK-PD) Modeling
2009
Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer Disease
2012
Predicting human exposure of active drug after oral prodrug administration, using a joined in vitro/in silico–in vivo extrapolation and physiologically-based pharmacokinetic modeling approach
2012
Explaining variability in ciclosporin exposure in adult kidney transplant recipients
2010
Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research
2008
THE PHARMACOKINETICS OF GLYCYRRHIZIC ACID EVALUATED BY PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING†
2001
Estimation of binding rate constants using a simultaneous mixed‐effects method: application to monoamine transporter reuptake inhibitor reboxetine
2010
Clinical Trial Simulation: A Review
2010
Mitotane has a strong and a durable inducing effect on CYP3A4 activity
2011
Mechanism-Based Pharmacokinetic-Pharmacodynamic Modeling: Biophase Distribution, Receptor Theory, and Dynamical Systems Analysis
2006
Model‐Based Dose Selection for Intravaginal Ring Formulations Releasing Anastrozole and Levonorgestrel Intended for the Treatment of Endometriosis Symptoms
2016